Elsevier

Vaccine

Volume 9, Issue 9, September 1991, Pages 643-647
Vaccine

Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies

https://doi.org/10.1016/0264-410X(91)90189-DGet rights and content

Abstract

A large double-blind, randomized, placebo-controlled trial of live attenuated Oka/Merck varicella vaccine was conducted among healthy children, 1–14 years of age. During the first varicella season, the efficacy of the vaccine among susceptible children was 100%1. During the second varicella season, 22 children were diagnosed with varicella: 21 cases in placebo recipients and one in a vaccine recipient. The overall efficacy of the vaccine through two varicella seaons was 98%. After the code for the study was broken, the original group of vaccine recipients continued to be followed for development of varicella. The estimated proportion of vaccine recipients who remained varicella-free at the end of 7 years was 95%. The 23 cases of varicella that occurred in vaccine recipients over the 7-year period were considerably milder than natural varicella. The average number of lesions was 53, 50% of the children had non-vesicular rashes, and 14% of the children had a temperature ⩾ 38.9°C (102°F), oral. The persistence of antibody in a subset of vaccine recipients followed for 6 years was 100%.

References (14)

  • P.J. Provost et al.

    Antibody assays suitable for assessing immune responses to live varicella vaccine

    Vaccine

    (1991)
  • H.H. Balfour et al.

    Acyclovir treatment of varicella in otherwise healthy children

    J. Pediatr.

    (1990)
  • R.E. Weibel et al.

    Live attenuated varicella virus vaccine

    N. Engl. J. Med.

    (1984)
  • A.A. Gershon et al.

    Detection of antibody to varicella-zoster virus by immune adherence hemagglutination

  • V. Williams et al.

    Serological responses to varicella zoster membrane antigens measured by indirect immunofluorescence

    J. Infect. Dis.

    (1974)
  • Z. Shehab et al.

    Enzyme-linked immunosorbent assay for susceptibility to varicella

    J. Infect. Dis.

    (1983)
  • E.A. Caunt et al.

    Neutralization tests with varicella-zoster virus

    J. Hyg. (London)

    (1969)
There are more references available in the full text version of this article.

Cited by (0)

View full text